WORLDHEART FILES PROXY FOR MEDQUEST ACQUISITION

WorldHeart announced that, following a review process by the Securities and Exchange Commission, it has filed its definitive proxy statement for its annual and special meeting of shareholders. Once WorldHeart concludes its shareholder meeting on July 18th, assuming shareholder approval, the company intends to close its previously announced acquisition of MedQuest Products, a private Salt Lake City, Utah-based medical device company, in the final development stages of its HeartQuest ventricular assist device.

()a href="http://www.newswire.ca/en/releases/archive/June2005/20/c4047.html" target="_blank">Canada NewsWire